NIH #1P01CA278735-01A1
Advancing Hormone Therapy for Endometrial Cancer
Active
- Amount
- $2.8M
- Period
- 2025-08-08 → 2030-07-31
- PIs
- 2
- Est. capacity / PI
- ~19 students
Awarded at UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
NIH #5R01CA289731-03
The combined role of ARID1A loss and estrogen signaling in endometrial cancer
Active
- Amount
- $422K
- Period
- 2024-03-04 → 2029-02-28
- PIs
- 2
- Est. capacity / PI
- ~1 students
Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH
NIH #5R01CA289731-02
The combined role of ARID1A loss and estrogen signaling in endometrial cancer
Active
- Amount
- $422K
- Period
- 2024-03-04 → 2029-02-28
- PIs
- 2
- Est. capacity / PI
- ~1 students
Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH
NIH #1R01CA289731-01
The combined role of ARID1A loss and estrogen signaling in endometrial cancer
Active
- Amount
- $422K
- Period
- 2024-03-04 → 2029-02-28
- PIs
- 2
- Est. capacity / PI
- ~1 students
Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH
NIH #5R21CA270580-02
Mechanisms of tamoxifen-associated endometrial cancer risk
- Amount
- $171K
- Period
- 2023-05-01 → 2026-04-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH
NIH #1R21CA270580-01A1
Mechanisms of tamoxifen-associated endometrial cancer risk
- Amount
- $216K
- Period
- 2023-05-01 → 2025-04-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH
NIH #5P30CA042014-32
Nuclear Control of Cell Growth and Differentiation (NC)
- Amount
- $62K
- Period
- 1997-05-09 → 2025-04-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH
NIH #1R21AG067350-01A1
In vivo multiplexed silencing of cis-elements in the brain
- Amount
- $419K
- Period
- 2021-05-01 → 2024-04-30
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH
NIH #5R01HG008974-05
In situ evaluation of combinatorial gene regulation in the human genome
- Amount
- $655K
- Period
- 2017-07-01 → 2023-04-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH
NIH #5R01HG008974-04
In situ evaluation of combinatorial gene regulation in the human genome
- Amount
- $655K
- Period
- 2017-07-01 → 2022-04-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH
NIH #5R01HG008974-03
In situ evaluation of combinatorial gene regulation in the human genome
- Amount
- $597K
- Period
- 2017-07-01 → 2022-04-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH
NIH #3R01HG008974-03S1
In situ evaluation of combinatorial gene regulation in the human genome
- Amount
- $57K
- Period
- 2017-07-01 → 2022-04-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH
NIH #5R01HG008974-02
In situ evaluation of combinatorial gene regulation in the human genome
- Amount
- $597K
- Period
- 2017-07-01 → 2022-04-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH
NIH #1R01HG008974-01A1
In situ evaluation of combinatorial gene regulation in the human genome
- Amount
- $594K
- Period
- 2017-07-01 → 2022-04-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH
NIH #5R21CA196455-03
Development of Enhancer RNA-based Biomarkers in FFPE Tissue
- Amount
- $227K
- Period
- 2015-09-01 → 2019-08-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH
NIH #5R21CA196455-02
Development of Enhancer RNA-based Biomarkers in FFPE Tissue
- Amount
- $227K
- Period
- 2015-09-01 → 2018-08-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH
NIH #1R21CA196455-01
Development of Enhancer RNA-based Biomarkers in FFPE Tissue
- Amount
- $194K
- Period
- 2015-09-01 → 2018-08-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH
NIH #5R00HG006922-05
Impact of enhancer sequence and interacting factors on estrogen receptor-mediated
- Amount
- $297K
- Period
- 2012-07-18 → 2017-11-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH
NIH #3R00HG006922-04S1
Impact of enhancer sequence and interacting factors on estrogen receptor-mediated
- Amount
- $17K
- Period
- 2015-07-01 → 2016-11-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH
NIH #5R00HG006922-04
Impact of enhancer sequence and interacting factors on estrogen receptor-mediated
- Amount
- $249K
- Period
- 2012-07-18 → 2016-11-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH
NIH #4R00HG006922-03
Impact of enhancer sequence and interacting factors on estrogen receptor-mediated
- Amount
- $248K
- Period
- 2012-07-18 → 2016-11-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH
NIH #1K99HG006922-01
Impact of enhancer sequence and interacting factors on estrogen receptor-mediated
- Amount
- $95K
- Period
- 2012-07-18 → 2014-04-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at HUDSON-ALPHA INSTITUTE FOR BIOTECHNOLOGY
NIH #5K99HG006922-02
Impact of enhancer sequence and interacting factors on estrogen receptor-mediated
- Amount
- $95K
- Period
- 2012-07-18 → 2013-10-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at HUDSON-ALPHA INSTITUTE FOR BIOTECHNOLOGY